MedPath

Influenza VLP study

Not Applicable
Conditions
Health Condition 1: J09X- Influenza due to identified novelinfluenza A virus
Registration Number
CTRI/2021/02/031006
Lead Sponsor
Manipal Institute of Virology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients positive for Influenza A(H1N1) and Influenza A(H3N2)

Exclusion Criteria

Patients negative for Influenza A(H1N1) and Influenza A(H3N2)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ï??Developing a VLP expressing both HA and NA antigens of Influenza A (H1N1) and Influenza A (H3N2) viruses will be a novel study. <br/ ><br>ï??No data is available in India on immunological responses to influenza virus and effect of pre-existing antibodies. This study will form a platform for future immune response studies. <br/ ><br>ï??The VLPs successfully developed as part of this study can be patented. <br/ ><br>Timepoint: 3 Years <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ï??No data is available in India on immunological responses to influenza virus and effect of pre-existing antibodies. This study will form a platform for future immune response studies.Timepoint: 3 Years
© Copyright 2025. All Rights Reserved by MedPath